Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with parkinson’s disease: a Meta-analysis of randomized controlled trials

References

• Obeso JA, Stamelou M, Goetz CG, et al. Past, present, and future of Parkinson's disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord. 2017;32(9):1264–1310.
   PubMed Web of Science ®Google Scholar
• Johnson SJ, Diener MD, Kaltenboeck A, et al. An economic model of Parkinson's disease: implications for slowing progression in the United States. Mov Disord. 2013;28(3):319–326.
   PubMed Web of Science ®Google Scholar
• Williams-Gray CH, Foltynie T, Brayne CE, et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain. 2007;130(Pt 7):1787–1798.
   PubMed Web of Science ®Google Scholar
• Seppi K, Ray Chaudhuri K, Coelho M, the orators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee, et al. Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review. Mov Disord. 2019;34(2):180–198.
   PubMed Web of Science ®Google Scholar
• Luber B, Lisanby SH. Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS). Neuroimage. 2014;85(Pt 3):961–970.
   PubMed Web of Science ®Google Scholar
• McGregor MM, Nelson AB. Circuit mechanisms of Parkinson's disease. Neuron. 2019;101(6):1042–1056.
   PubMed Web of Science ®Google Scholar
• Vanderhasselt MA, De Raedt R, Baeken C, et al. The influence of rTMS over the left dorsolateral prefrontal cortex on Stroop task performance. Exp Brain Res. 2006;169(2):279–282.
   PubMed Web of Science ®Google Scholar
• Klimesch W, Sauseng P, Gerloff C. Enhancing cognitive performance with repetitive transcranial magnetic stimulation at human individual alpha frequency. Eur J Neurosci. 2003;17(5):1129–1133.
   PubMed Web of Science ®Google Scholar
• Cappa SF, Sandrini M, Rossini PM, et al. The role of the left frontal lobe in action naming: rTMS evidence. Neurology. 2002;59(5):720–723.
   PubMed Web of Science ®Google Scholar
• Ba F, Zhou Y, Zhou J, et al. Repetitive transcranial magnetic stimulation protects mice against 6-OHDA-induced Parkinson's disease symptoms by regulating brain amyloid β1-42 level. Mol Cell Biochem. 2019;458(1-2):71–78.
   PubMed Web of Science ®Google Scholar
• Boggio PS, Fregni F, Bermpohl F, et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Mov Disord. 2005;20(9):1178–1184. ‐
   PubMed Web of Science ®Google Scholar
• Fregni F, Santos CM, Myczkowski ML, et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75(8):1171–1174.
   PubMed Web of Science ®Google Scholar
• Benninger DH, Berman BD, Houdayer E, Pal N, et al. Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease. Neurology. 2011;76(7):601–609.
   PubMed Web of Science ®Google Scholar
• Benninger DH, Iseki K, Kranick S, et al. Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson disease. Neurorehabil Neural Repair. 2012;26(9):1096–1105.
   PubMed Web of Science ®Google Scholar
• Makkos A, Pál E, Aschermann Z, et al. High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson's Disease: a Randomized, Double-Blind, Placebo-Controlled Study. Neuropsychobiology. 2016;73(3):169–177.
   PubMed Web of Science ®Google Scholar
• Pal E, Nagy F, Aschermann Z, et al. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study. Mov Disord. 2010;25(14):2311–2317.
   PubMed Web of Science ®Google Scholar
• Randver R, Davel K, Toomsoo T. High-frequency repetitive transcranial magnetic stimulation to the left dorsolateral prefrontal cortex of patients with Parkinson's disease and treatment-resistant depression: a pilot study. Neurocase. 2019;25(3-4):80–90.
   PubMed Web of Science ®Google Scholar
• Goodwill AM, Lum JAG, Hendy AM, et al. Using non-invasive transcranial stimulation to improve motor and cognitive function in Parkinson's disease: a systematic review and meta-analysis. Sci Rep. 2017;7(1):14840.
   PubMed Web of Science ®Google Scholar
• Lawrence BJ, Gasson N, Bucks RS, et al. Cognitive training and noninvasive brain stimulation for cognition in Parkinson's disease: a meta-analysis. Neurorehabil Neural Repair. 2017;31(7):597–608.
   PubMed Web of Science ®Google Scholar
• Oh E, Park S, Lim J, et al. High frequency repetitive transcranial magnetic stimulation for freezing of gait and nonmotor symptoms in Parkinson's disease. J Korean Neurol Assoc. 2015;33(4):297–305.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012.
   PubMed Web of Science ®Google Scholar
• Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement Disorder Society Task Force guidelines. Mov Disord. 2012;27(3):349–356.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2019;366:l4898. DOI:https://doi.org/10.1136/bmj.l4898
   Google Scholar
• Jiang B, He D. Repetitive transcranial magnetic stimulation (rTMS) fails to increase serum brain-derived neurotrophic factor (BDNF). Neurophysiol Clin. 2019;49(4):295–300.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
   PubMed Web of Science ®Google Scholar
• Srovnalova H, Marecek R, Rektorova I. The role of the inferior frontal gyri in cognitive processing of patients with Parkinson's disease: a pilot rTMS study. Mov Disord. 2011;26(8):1545–1548.
   PubMed Web of Science ®Google Scholar
• Srovnalova H, Marecek R, Kubikova R, et al. The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson's disease. Exp Brain Res. 2012;223(2):251–257.
   PubMed Web of Science ®Google Scholar
• Sedlackova S, Rektorova I, Srovnalova H, et al. Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson's disease. J Neural Transm (Vienna). 2009;116(9):1093–1101.
   PubMed Web of Science ®Google Scholar
• Trung J, Hanganu A, Jobert S, et al. Transcranial magnetic stimulation improves cognition over time in Parkinson's disease. Parkinsonism Relat Disord. 2019;66:3–8.
   PubMed Web of Science ®Google Scholar
• Hill AT, McModie S, Fung W, et al. Impact of prefrontal intermittent theta-burst stimulation on working memory and executive function in Parkinson's disease: a double-blind sham-controlled pilot study. Brain Res. 2020;1726:146506.
   PubMed Web of Science ®Google Scholar
• Khedr EM, Mohamed KO, Ali AM, et al. The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: pilot study. Restor Neurol Neurosci. 2020;38(1):55–66.
   PubMed Web of Science ®Google Scholar
• Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135
   PubMed Web of Science ®Google Scholar
• Martin DM, McClintock SM, Forster J, et al. Does therapeutic repetitive transcranial magnetic stimulation cause cognitive enhancing effects in patients with neuropsychiatric conditions? A systematic review and meta-analysis of randomised controlled trials. Neuropsychol Rev. 2016;26(3):295–309.
   PubMed Web of Science ®Google Scholar
• Huang YZ, Edwards MJ, Rounis E, et al. Theta burst stimulation of the human motor cortex. Neuron. 2005;45(2):201–206.
   PubMed Web of Science ®Google Scholar
• Kehagia AA, Barker RA, Robbins TW. Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis. Neurodegener Dis. 2013;11(2):79–92.
   PubMed Web of Science ®Google Scholar
• Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, et al. Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. NPJ Parkinsons Dis. 2018;4:19.
   PubMed Web of Science ®Google Scholar
• Wang X, Mao Z, Ling Z, et al. Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials. J Neurol. 2020;267(3):791–801.
   PubMed Web of Science ®Google Scholar
• Latorre A, Rocchi L, Berardelli A, et al. The use of transcranial magnetic stimulation as a treatment for movement disorders: a critical review. Mov Disord. 2019;34(6):769–782.
   PubMed Web of Science ®Google Scholar
• Dubois B, Slachevsky A, Litvan I, et al. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11):1621–1626.
   PubMed Web of Science ®Google Scholar
• Martin DM, McClintock SM, Forster JJ, et al. Cognitive enhancing effects of rTMS administered to the prefrontal cortex in patients with depression: a systematic review and meta-analysis of individual task effects. Depress Anxiety. 2017;34(11):1029–1039.
   PubMed Web of Science ®Google Scholar
• McGough EL, Kelly VE, Logsdon RG, McCurry SM, et al. Associations between physical performance and executive function in older adults with mild cognitive impairment: gait speed and the timed "up & go" test. Physical Therapy. 2011;91(8):1198–1207.
   PubMed Web of Science ®Google Scholar
• Lange F, Bruckner C, Knebel A, et al. Executive dysfunction in Parkinson's disease: a meta-analysis on the Wisconsin Card Sorting Test literature. Neurosci Biobehav Rev. 2018;93:38–56.
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Kumaran SS, Kaloiya GS, et al. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment. J Clin Neurosci. 2020;75:99–105.
   PubMed Web of Science ®Google Scholar
• Thiele A, Bellgrove MA. Neuromodulation of attention. Neuron. 2018;97(4):769–785.
   PubMed Web of Science ®Google Scholar
• Ma S, Hangya B, Leonard CS, et al. Dual-transmitter systems regulating arousal, attention, learning and memory. Neurosci Biobehav Rev. 2018;85:21–33.
   PubMed Web of Science ®Google Scholar
• Ko JH, Monchi O, Ptito A, et al. Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study. Eur J Neurosci. 2008;28(10):2147–2155.
   PubMed Web of Science ®Google Scholar